Clik here to view.
Cell Therapeutics Back at the Capital Well (CTIC)
Cell Therapeutics, Inc. (NASDAQ: CTIC) is one that many will have forgotten about or one that many wish they had forgotten about. Now the company is in the news after announcing a securities purchase...
View ArticleClik here to view.
Prana: A Speculative Ten-Bagger Scenario (PRAN)
This last week brought an interesting move in shares of Prana Biotechnology Ltd. (NASDAQ: PRAN). On Friday we gave this coverage right at the open noting at 24/7 Wall Street that the stock was still...
View ArticleQuest for $1,000 Genome: Complete Genomics Raises Expansion Capital (GNOM)
COMPLETE GENOMICS, INC. (NASDAQ: GNOM) has filed to raise up to $75 million in cash in a public stock offering. The filing is for 4.5 million shares, or it would be 5.175 million shares if the...
View ArticleShouldn’t VIVUS Raise Capital Now? (VVUS)
While we have started mostly using The Wire at 247wallst.com for our biotech and active trader posts (among many other aspects 50 to 100 times per day), we have a question for BioHealthInvestor readers...
View Article
